Specific increase of human kallikrein 4 mRNA and protein levels in breast cancer stromal cells

Archive ouverte

Mangé, Alain | Desmetz, Caroline | Berthes, Marie-Laurence | Maudelonde, Thierry | Solassol, Jérôme

Edité par CCSD ; Elsevier -

International audience. The kallikrein family (KLK) has been implicated in cancer and may be useful as tumor markers. Here, we compared the 15 KLK genes' expression in malignant and normal breast tissues using real-time quantitative PCR. Most KLKs were expressed at lower levels in breast cancer compared to normal breast tissue. The only exception was the eightfold increase level of KLK4 in breast cancer tissues (P=0.008). KLK4 level was strongly associated with tumor grade (P=0.0015). Interestingly, based on laser cell microdissection analysis and immunochemistry, the up-regulation of kallikrein 4 occurred in the surrounding stromal cells. Our findings suggest that KLK4 may be associated with the development and progression of breast cancer and suggest its potential use in breast cancer monitoring.

Consulter en ligne

Suggestions

Du même auteur

Identifying autoantibody signatures in cancer: a promising challenge

Archive ouverte | Desmetz, Caroline | CCSD

International audience. Biomarkers that show high sensitivity and specificity are needed for the early diagnosis and prognosis of cancer. An immune response to cancer is elicited in humans, as demonstrated, in part,...

[Serum autoantibodies profiling and early-stage cancer detection].. Autoanticorps et diagnostic précoce des cancers

Archive ouverte | Desmetz, Caroline | CCSD

International audience. It is now well established that an immune response to cancer is elicited in humans, as demonstrated in part by the identification of autoantibodies against a number of tumor-associated antige...

Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women

Archive ouverte | Desmetz, Caroline | CCSD

International audience. We examined the feasibility of using a panel of autoantibodies to multiple tumor-associated proteins as a method for early detection of breast cancer and, more particularly, carcinoma in situ...

Chargement des enrichissements...